期刊文献+

唑来膦酸联合放疗治疗骨转移癌55例 被引量:7

原文传递
导出
摘要 目的探讨唑来膦酸联合放疗治疗骨转移癌疼痛的效果。方法112例骨转移癌患者分成观察组(55例)和对照组(57例),观察组为局部放疗+唑来膦酸静脉滴注,唑来膦酸用法为4mg/次,1次/月,共2~4次;对照组为单纯放疗。两组放疗方法一致,DT30Gy/10次。结果治疗结束时观察组和对照组疼痛缓解率分别为89.1%和80.7%(P〉0.05),生存质量改善率分别为87.3%和70.2%(P〈0.05);3个月后随访观察组和对照组疼痛缓解率分别为85.5%和61.4%(P〈0.05)。结论唑来膦酸联合放疗对骨转移癌止痛效果好,患者生存质量较单纯放射治疗明显提高。
出处 《肿瘤研究与临床》 CAS 2009年第4期264-266,共3页 Cancer Research and Clinic
  • 相关文献

参考文献8

  • 1Porter AT, Fontanesi J. Palliative irradiation for bone metastasis: a new paradigm. Int J Radiat Oncol Biol Phys, 1994, 29:1199-1200.
  • 2牛润桂.唑来膦酸治疗癌性骨转移疼痛的有效性和安全性研究[J].肿瘤研究与临床,2007,19(2):122-124. 被引量:3
  • 3Rosen LS, Gordon D, Kaminski M, et al. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complication in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer, 2003, 98: 1735-1744.
  • 4Rosen LS, Gordon D, Tchekmedyian NS, et al. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with non small cell lung carcinoma and other solid tumors: a randomized phase In ,double-blind, placebo-controlled trial. Cancer, 2004, 100: 2613-2621.
  • 5Ural AU, Avcu F, Candir M, et al. In vitro synergistic cytoreductive effects of Zoledronic acid and radiation on breast cancer cells. Breast Cancer Res, 2006, 8: R52.
  • 6Arrington SA, Damron TA, Mann KA, et al. Concurrent administration of zoledronic acid and irradiation leads to improves bone density, biomechanical strength and microarchitecture in a mouse model of tumor-induced osteolysis. J Surg Oncol, 2008, 97: 284-290.
  • 7Kohno N. Treatment of breast cancer with bone metastasis: bisphosphonate treatment-current and future. Int J Clin Oncol, 2005, 13: 18-23.
  • 8Coleman RE. Emerging strategies in bone health management for the adjuvant patient. Semin Oncol, 2007, 34:S11-16.

二级参考文献2

共引文献2

同被引文献57

  • 1牛润桂.唑来膦酸治疗癌性骨转移疼痛的有效性和安全性研究[J].肿瘤研究与临床,2007,19(2):122-124. 被引量:3
  • 2蒋爱梅,郉海霞,普萍,马黎明,董坚.三种乳腺癌骨转移模型复制方法比较研究[J].昆明医学院学报,2007,28(1):14-18. 被引量:5
  • 3Filzgarald RH,Kaufer H,Malkani A.Orthopaedics[M].London:Mos-by Inc,2002:1078-1088.
  • 4Akhtari M,Mensuri J,Newman KA,et al.Biology of breast cancer bone metastasis[J].Cancer Biol Ther,2008,7(1):3-9.
  • 5Coronado M,Redondo A,Coya J,et al.Clinical role of Sm-153 EDTMP in the treatment of painful bone metastatic disease[J].Clin Nucl Med,2006,31(10):605-610.
  • 6Mundy GR.Metastasis to bone:causes,consequences and therapeutic opportanities[J].Nat Rev Cancer,2002,2(8):584-593.
  • 7Vander-Linden YM,Dijkstra SP,Vonk EJ,et al.Prediction of survival in patients with metastases in the spinal column:resuits based on a randomized trial of radiotherapy[J].Cancer,2005,103(2):320-328.
  • 8Luckman SP,Hughes DE,Coxon FP,et al.Nitrogen-containing bisphosphonates inhibit the mevalonate path way and prevent poat translational prenylation of GTP-binding proteins,including Ras[J].J Bone Miner Res,1998,13:581-589.
  • 9Hughes DE,Wright KR,Uy HL,et al.Bisphosphonates promote apoptosis in murine osteoclasts in vitro and invixo[J].J Bone Miner Res,1995,10:1478-1487.
  • 10Ferretti G,Fabi A,Carlini P,et al.Zoledronic-acidinduced circulating level modifications of angiogenicfactors,metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients[J].Oncology,2005,69(1):35-43.

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部